- NEWS
Rare COVID reactions might hold key to variant-proof vaccines
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 592, 20-21 (2021)
doi: https://doi.org/10.1038/d41586-021-00722-8
References
Moyo-Gwete, T. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.03.06.434193 (2021).
Xie, X. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.01.07.425740 (2021).
Cele, S. et al. Preprint at medRxiv https://doi.org/10.1101/2021.01.26.21250224 (2021).
Shinde, V. et al. Preprint at medRxiv https://doi.org/10.1101/2021.02.25.21252477 (2021).
Madhi, S. A. et al. New Eng. J. Med. https://doi.org/10.1056/NEJMoa2102214 (2021).
Faulkner, N. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.03.01.433314 (2021).
Muecksch, F. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.03.07.434227 (2021).
Stamatatos, L. et al. Preprint at medRxiv https://doi.org/10.1101/2021.02.05.21251182 (2021).